Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab maintenance versus observation in aggressive B-cell lymphoma
2005-005187-90Phase 3Completed
- Sponsor
- AGMT: Arbeitsgemeinschaft Medikamentöse Tumortherapie
- Start
- Jul 2006
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3, randomised trial in non-Hodgkin lymphoma (NHL) comparing Rituximab maintenance with Observation alone (2 arms). Primary endpoint: Event-free survival. Started Jul 2006; status: completed.
02
Drugs
rituximab
03
Conditions
non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on 2005-005187-90.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005187-90.